Apremilast

Generic name: Apremilast
Brand names: Otezla
Dosage form: oral tablet (10 mg-20 mg-30 mg; 30 mg)
Drug class: Antirheumatics

Usage of Apremilast

Apremilast is a phosphodiesterase 4 (PDE4) inhibitor that works to suppress the immune system, which reduces inflammation.

Apremilast is used to treat active psoriatic arthritis in adults.

Apremilast is also used to treat moderate to severe plaque psoriasis in adults who may also receive phototherapy or other treatments for psoriasis.

Apremilast is also used to treat mouth ulcers in adults with Behçet's disease (a disease causing inflammation in blood vessels).

Apremilast side effects

Get emergency medical help if you have signs of an allergic reaction to apremilast: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Call your doctor at once if you have:

severe diarrhea, nausea, and vomiting;

unexplained weight loss, or if you lose a lot of weight;

mood changes, new or worsening depression; or

thoughts of suicide or hurting yourself.

Common apremilast side effects may include:

nausea, diarrhea;

headache; or

cold symptoms such as stuffy nose, sneezing, sore throat.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Before taking Apremilast

You should not use apremilast if you are allergic to it.

To make sure this medicine is safe for you, tell your doctor if you have ever had:

kidney disease; or

depression or suicidal thoughts or actions.

Some people have thoughts about suicide while taking apremilast. Your doctor will need to check your progress at regular visits. Your family or other caregivers should also be alert to changes in your mood or symptoms.

Apremilast may harm an unborn baby. Use effective birth control to prevent pregnancy, and tell your doctor if you become pregnant.

If you are pregnant, your name may be listed on a pregnancy registry to track the effects of apremilast on the baby.

It may not be safe to breastfeed while using this medicine. Ask your doctor about any risk.

Apremilast is not approved for use by anyone younger than 18 years old.

Relate drugs

How to use Apremilast

Usual Adult Dose for Psoriatic Arthritis:

Initial dose: -Day 1: 10 mg orally once a day (AM) -Day 2: 10 mg orally twice a day (AM and PM) -Day 3: 10 mg orally once a day (AM); 20 mg orally once a day (PM) -Day 4: 20 mg orally twice a day (AM and PM) -Day 5: 20 mg orally once a day (AM); 30 mg orally once a day (PM) Maintenance dose: 30 mg orally twice a day (AM and PM) Comments: This titration is intended to reduce the gastrointestinal symptoms associated with initial therapy. Use: Treatment of adult patients with active psoriatic arthritis

Warnings

Some people have thoughts about suicide while taking apremilast. Stay alert to changes in your mood or symptoms. Report any new or worsening symptoms to your doctor.

What other drugs will affect Apremilast

Sometimes it is not safe to use certain medications at the same time. Some drugs can affect your blood levels of other drugs you take, which may increase side effects or make the medications less effective.

Other drugs may interact with apremilast, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all your current medicines and any medicine you start or stop using.

Popular FAQ

Sotyktu and Otezla are both oral prescription medicines used to treat moderate-to-severe plaque psoriasis, but they work in different ways. Sotyktu blocks a protein called TYK2 (tyrosine kinase 2) to help lower inflammation and improve the severity and number of psoriasis lesions. Otezla works by blocking the phosphodiesterase type 4 (PDE4) enzyme to lower inflammation. Continue reading

Otezla is made by Amgen Inc, located in Thousand Oaks, California. Otezla is expensive because it is a brand name drug. The lower-cost generic option called apremilast was approved by the FDA in February 2021, but it is not yet on the U.S. market, possibly due to ongoing patent protection. Continue reading

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.